ABC Link at National Lawyers Assn Conference

ABORTION-BREAST CANCER LINK, HORMONES DISCUSSED AT NATIONAL LAWYERS ASSOCIATION CONFERENCE

Attorneys attending a conference sponsored by the National Lawyers Association at Chicago's Kent College of Law on August 1 heard speakers discuss the abortion-breast cancer (ABC) link and the role of hormones in the development of breast cancer.

Mayer Eisenstein, MD, JD, MPH, said that estrogen is connected with the development of most breast cancers.  Eisenstein's speech is relevant to the ABC link because women are exposed to more estrogen during normal pregnancies (but not most miscarriages) than at any other time during their lives.  This effect is only corrected in the third trimester when breast cells are matured into cancer-resistant tissue.

The government's Report on Carcinogens included steroidal estrogens (used in oral contraceptives and estrogen replacement therapy) on its list of "known carcinogens" last year.

Eisenstein said, "Anyone who's on (them) unavoidably increases breast cancer risk."  Having more children, starting at an earlier age, reduces lifetime risk.

Cancer-Causing Birth Control Pills

Johnson & Johnson's Sales of Cancer-Causing Birth Control Pills Comparable to Tobacco Industry's Corporate Greed, Says Coalition on Abortion/Breast Cancer

"Real hatred of women involves their exploitation through sales of cancer-causing hormonal contraceptive steroids," Karen Malec, president of the Coalition on Abortion/Breast Cancer.

The Coalition on Abortion/Breast Cancer condemns Johnson & Johnson's and its shareholders' decision to continue selling cancer-causing birth control pills to young women instead of protecting their lives and striving to reduce breast cancer rates.

On April 28, 2011, Dr. Chris Kahlenborn, a medical adviser for the Coalition, presented a resolution at a shareholder's meeting on behalf of a shareholder, Human Life International. The resolution proposed a change in J&J's policy - that it would not discriminate in employment against breast cancer survivors, including those voicing opposition to the sale of the pill. Shareholders rejected the proposal after J&J's board sent a message saying they "did not believe the resolution is necessary."